Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1–24.1

Comparative genomic hybridization (CGH) analysis was used to identify chromosomal imbalances in 52 human primary hepatocellular carcinomas (HCCs). The most prominent changes were gains of part or all of chromosome arms 8q (83% of cases) and 1q (73%) and loss of 16q (63%). Other commonly overrepresented sites were 5p, 7q, and Xq. Recurrent sites of DNA sequence amplification included 8q23–24 (five cases) and 11q13–14 (four cases). Other frequently underrepresented sites were 4q, 8p, 16p, and 17p. Taken collectively, these findings and data from other CGH studies of HCCs define a subset of chromosome segments that are consistently over‐ or underrepresented and highlight sites of putative oncogenes and tumor suppressor genes, respectively, involved in hepatocellular oncogenesis. Loss of heterozygosity analysis with a panel of polymorphic microsatellite markers distributed along 16q defined a minimal region of chromosomal loss at 16q23.1–24.1, suggesting that this region harbors a tumor suppressor gene whose loss/inactivation may contribute to the pathogenesis of many HCCs. © 2000 Wiley‐Liss, Inc.

[1]  T. Sodeyama,et al.  [Global epidemiology of hepatocellular carcinoma]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[2]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[3]  M. Emi,et al.  Identification of a 1‐Mb common region at 16q24.1–24.2 deleted in hepatocellular carcinoma , 2000, Genes, chromosomes & cancer.

[4]  Yusuke Nakamura,et al.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.

[5]  Y. Nakamura,et al.  Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization , 1999, British Journal of Cancer.

[6]  M. Emi,et al.  Identification of a 1‐cM region of common deletion on 4q35 associated with progression of hepatocellular carcinoma , 1999, Genes, chromosomes & cancer.

[7]  K. Okita,et al.  Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: Their relationship to clinicopathological features , 1999, Hepatology.

[8]  K. Porkka,et al.  Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. , 1999, The American journal of pathology.

[9]  G. Gyapay,et al.  Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma , 1999, Oncogene.

[10]  Z. Piao,et al.  Deletion mapping of chromosome 16q in hepatocellular carcinoma , 1999, British Journal of Cancer.

[11]  H. McLeod,et al.  Comparative genomic hybridization and chromosomal instability in solid tumours , 1999, British Journal of Cancer.

[12]  S. Thorgeirsson,et al.  Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization , 1999, Hepatology.

[13]  J. Sheu,et al.  Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridisation in Taiwan. , 1999, European journal of cancer.

[14]  S. Hirohashi,et al.  DNA hypermethylation at the D17S5 locus and reduced HIC‐1mRNA expression are associated with hepatocarcinogenesis , 1999, Hepatology.

[15]  B. Johansson,et al.  Frequent rearrangements of chromosomes 1, 7, and 8 in primary liver cancer , 1998, Genes, chromosomes & cancer.

[16]  D. Weiner,et al.  HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Jeng,et al.  Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan. , 1998, Cancer letters.

[18]  A. Puisieux,et al.  TP53 and hepatocellular carcinoma. , 1997, Pathologie-biologie.

[19]  M. Buendia,et al.  Comprehensive allelotyping of human hepatocellular carcinoma , 1997, Oncogene.

[20]  S. Manoir,et al.  Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. , 1997, Cancer research.

[21]  J. Fujimoto,et al.  Expression of hepatocyte growth factor and its receptor c‐met proto‐oncogene in hepatocellular carcinoma , 1997, Hepatology.

[22]  O. Cussenot,et al.  Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. , 1997, Cancer research.

[23]  A. Sahin,et al.  Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. , 1996, Cancer research.

[24]  P. Pineau,et al.  Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization , 1996, Genes, chromosomes & cancer.

[25]  S. Takeda,et al.  Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis. , 1996, Seminars in surgical oncology.

[26]  M. Washington,et al.  M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity , 1995, Nature Genetics.

[27]  G. Gaidano,et al.  Centromeric instability of chromosome 1 resulting in multibranched chromosomes, telomeric fusions, and ‘jumping translocations’ of 1q in a human immunodeficiency virus‐related non‐Hodgkin's lymphoma , 1995, Cancer.

[28]  K. Buetow,et al.  Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  N. Habib,et al.  Loss of heterozygosity in liver tumours. , 1995, Journal of hepatology.

[30]  E. Tabor Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus‐associated hepatocellular carcinoma , 1994, Journal of medical virology.

[31]  C. J. Chen,et al.  Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. , 1993, Biochemical and biophysical research communications.

[32]  Y. Nakamura,et al.  Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. , 1993, Cancer research.

[33]  D Rutovitz,et al.  Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. , 1993, Seminars in cancer biology.

[34]  A. Weith,et al.  Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. , 1991, Oncogene.

[35]  S. Hirohashi,et al.  Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Buetow,et al.  Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Ochiya,et al.  Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma. , 1988, Oncogene.

[38]  R. Beasley Hepatitis B virus. The major etiology of hepatocellular carcinoma , 1988, Cancer.

[39]  W. Rutter,et al.  Integration of hepatitis B virus DNA in chromosome-specific satellite sequences , 1986, Journal of virology.

[40]  J. Rowley Mapping of human chromosomal regions related to neoplasia: evidence from chromosomes 1 and 17. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[41]  N. Wong,et al.  Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. , 1999, The American journal of pathology.

[42]  M R Speicher,et al.  Quantitative analysis of comparative genomic hybridization. , 1995, Cytometry.

[43]  T. Ishikawa,et al.  Allelotype study of primary hepatocellular carcinoma. , 1991, Cancer research.